Form 8-K - Current report:
SEC Accession No. 0000950170-25-087924
Filing Date
2025-06-18
Accepted
2025-06-18 16:30:31
Documents
10
Period of Report
2025-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K mnov-20250617.htm   iXBRL 8-K 95310
  Complete submission text file 0000950170-25-087924.txt   210178

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnov-20250617.xsd EX-101.SCH 30878
12 EXTRACTED XBRL INSTANCE DOCUMENT mnov-20250617_htm.xml XML 4694
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33185 | Film No.: 251057347
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)